Usefulness of Plasma B-Type Natriuretic Peptide Levels in Predicting the Need for an Additional Ibuprofen Dose in Hemodynamically Significant Patent Ductus Arteriosus
Perinatology · 2026 · 37 (1) · 9
DOI: 10.14734/pn.2026.37.1.9 ↗Kurz gefasst
Fachartikel in der Zeitschrift Perinatology, 2026. Verfasst von Hye Won Cho und 4 weiteren Autor:innen. Die Arbeit nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Objective
We investigated the usefulness of the plasma B-type natriuretic peptide (BNP) levels measured 24 hours after the last ibuprofen dose in predicting the need for an additional dose to prevent the recurrence of symptomatic patent ductus arteriosus (PDA) following completion of the planned pharmacological treatment.
Methods
Seventy-one preterm infants with hemodynamically significant (hs) PDA, whose plasma BNP levels were measured just before and 24 hours after the last ibuprofen dose were enrolled.Subjects were classified as the sufficient dosing group (n=50, no hsPDA recurrence within 5 days after the last ibuprofen dose) or the insufficient dosing group (n=21, hsPDA recurrence within 5 days requiring additional ibuprofen).
Results
Plasma BNP levels 24 hours after the last dose were significantly lower in the sufficient dosing group than in the insufficient dosing group (177 [89-310] vs. 483 [222-1,027] pg/mL, P=0.006).The area under the receiver operating characteristic curve for plasma BNP levels in predicting the need for an additional ibuprofen dose was 0.890 (95% confidence interval, 0.812-0.967;P 462 pg/mL (sensitivity 71.4%, specificity 82.0%).
Conclusion
Plasma BNP levels measured 24 hours after completion of ibuprofen therapy can serve as a useful biomarker for identifying preterm infants at risk of recurrent hsPDA who may require additional ibuprofen treatment.These findings support the potential for individualized, BNP-guided therapy to reduce hsPDA recurrence and avoid unnecessary drug exposure.
Zitieren
APA
Cho, H. W., Choi, E. K., Lee, E. H., Park, K. H., & Choi, B. M. (2026). Usefulness of Plasma B-Type Natriuretic Peptide Levels in Predicting the Need for an Additional Ibuprofen Dose in Hemodynamically Significant Patent Ductus Arteriosus. Perinatology, 37(1), 9. https://doi.org/10.14734/pn.2026.37.1.9
Vancouver
Cho HW, Choi EK, Lee EH, Park KH, Choi BM. Usefulness of Plasma B-Type Natriuretic Peptide Levels in Predicting the Need for an Additional Ibuprofen Dose in Hemodynamically Significant Patent Ductus Arteriosus. Perinatology. 2026;37(1):9. doi:10.14734/pn.2026.37.1.9
BibTeX
@article{Cho2026,
author = {Cho, Hye Won and Choi, Eui Kyung and Lee, Eun Hee and Park, Kyu Hee and Choi, Byung Min},
title = {Usefulness of Plasma B-Type Natriuretic Peptide Levels in Predicting the Need for an Additional Ibuprofen Dose in Hemodynamically Significant Patent Ductus Arteriosus},
journal = {Perinatology},
year = {2026},
volume = {37},
number = {1},
pages = {9},
doi = {10.14734/pn.2026.37.1.9}
}
EUVIMED